author-photo

Karen P. Briscoe

20

Papers

204

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in.

2020 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (32)
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV): a randomised, placebo-controlled, phase 2 crossover trial

2020 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (10)
Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC/cannabis extract for refractory chemotherapy-induced nausea and vomiting (CINV).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration resistant prostate cancer

2019
Show All
- Source
- Cite
- Save
Citations (1)
OA08.02 DREAM - A Phase 2 Trial of Durvalumab with First Line Chemotherapy in Mesothelioma: Final Result

2018 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (28)
Pilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV).

2018 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

2018 BMJ Open
Show All
- Source
- Cite
- Save
Citations (7)
1805TiPPilot and definitive randomised double-blind placebo-controlled trials evaluating an oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting (CINV)

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer

2017 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (31)
A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer

2017 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)